Almost everyone knows someone who has migraine, but they may not know that this neurological disease impacts 41 million people in Europe and is the second leading cause of disability in the world. Migraine is not just a bad headache, it is a complex neurological disease that has a crippling effect on people’s lives. If left unchecked, migraine presents a devastating public health crisis that robs people of their right to work, right to participate and right to live fully. We are in the midst of a new generation of treatments for migraine and with it comes a new optimism; Lilly is committed to bringing life-changing solutions to people living with migraine so they lead to a life lived more fully.